These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 25625664
1. Remodeling of phospholipid composition in colon cancer cells by 1α,25(OH)2D3 and its analogs. Leyssens C, Marien E, Verlinden L, Derua R, Waelkens E, Swinnen JV, Verstuyf A. J Steroid Biochem Mol Biol; 2015 Apr; 148():172-8. PubMed ID: 25625664 [Abstract] [Full Text] [Related]
2. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly. Reddy GS, Robinson M, Wang G, Palmore GT, Gennaro L, Vouros P, De Clercq P, Vandewalle M, Young W, Ling S, Verstuyf A, Bouillon R. Arch Biochem Biophys; 2007 Apr 15; 460(2):254-61. PubMed ID: 17196157 [Abstract] [Full Text] [Related]
3. Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific. Zhao J, Tan BK, Marcelis S, Verstuyf A, Bouillon R. J Steroid Biochem Mol Biol; 1996 Feb 15; 57(3-4):197-202. PubMed ID: 8645629 [Abstract] [Full Text] [Related]
4. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Aguilera O, Peña C, García JM, Larriba MJ, Ordóñez-Morán P, Navarro D, Barbáchano A, López de Silanes I, Ballestar E, Fraga MF, Esteller M, Gamallo C, Bonilla F, González-Sancho JM, Muñoz A. Carcinogenesis; 2007 Sep 15; 28(9):1877-84. PubMed ID: 17449905 [Abstract] [Full Text] [Related]
5. Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. González-Sancho JM, Larriba MJ, Ordóñez-Morán P, Pálmer HG, Muñoz A. Anticancer Res; 2006 Sep 15; 26(4A):2669-81. PubMed ID: 16886677 [Abstract] [Full Text] [Related]
6. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Fernandez-Garcia NI, Palmer HG, Garcia M, Gonzalez-Martin A, del Rio M, Barettino D, Volpert O, Muñoz A, Jimenez B. Oncogene; 2005 Sep 29; 24(43):6533-44. PubMed ID: 16007183 [Abstract] [Full Text] [Related]
7. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. Tong WM, Hofer H, Ellinger A, Peterlik M, Cross HS. Oncol Res; 1999 Sep 29; 11(2):77-84. PubMed ID: 10489163 [Abstract] [Full Text] [Related]
8. CD-ring modified vitamin D3 analogs and their superagonistic action. Eelen G, Verlinden L, Bouillon R, De Clercq P, Muñoz A, Verstuyf A. J Steroid Biochem Mol Biol; 2010 Jul 29; 121(1-2):417-9. PubMed ID: 20132886 [Abstract] [Full Text] [Related]
9. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway. Reddy GS, Rao DS, Siu-Caldera ML, Astecker N, Weiskopf A, Vouros P, Sasso GJ, Manchand PS, Uskokovic MR. Arch Biochem Biophys; 2000 Nov 15; 383(2):197-205. PubMed ID: 11185554 [Abstract] [Full Text] [Related]
10. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF. Clin Cancer Res; 2000 Mar 15; 6(3):901-8. PubMed ID: 10741714 [Abstract] [Full Text] [Related]
11. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3. Takano M, Sawada D, Yasuda K, Nishikawa M, Takeuchi A, Takagi K, Horie K, Reddy GS, Chen TC, Sakaki T, Kittaka A. J Steroid Biochem Mol Biol; 2015 Apr 15; 148():34-7. PubMed ID: 25263656 [Abstract] [Full Text] [Related]
12. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP. Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668 [Abstract] [Full Text] [Related]
13. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Myrthue A, Rademacher BL, Pittsenbarger J, Kutyba-Brooks B, Gantner M, Qian DZ, Beer TM. Clin Cancer Res; 2008 Jun 01; 14(11):3562-70. PubMed ID: 18519790 [Abstract] [Full Text] [Related]
14. 1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. Chen S, Zhu J, Zuo S, Ma J, Zhang J, Chen G, Wang X, Pan Y, Liu Y, Wang P. Biochem Biophys Res Commun; 2008 Jun 01; 468(1-2):130-5. PubMed ID: 26523511 [Abstract] [Full Text] [Related]
15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S, Krishnan AV, Feldman D. Clin Cancer Res; 2000 Aug 01; 6(8):3371-9. PubMed ID: 10955825 [Abstract] [Full Text] [Related]
16. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia. Yu J, Papavasiliou V, Rhim J, Goltzman D, Kremer R. Anticancer Drugs; 1995 Feb 01; 6(1):101-8. PubMed ID: 7756673 [Abstract] [Full Text] [Related]
17. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. Campbell MJ, Reddy GS, Koeffler HP. J Cell Biochem; 1997 Sep 01; 66(3):413-25. PubMed ID: 9257197 [Abstract] [Full Text] [Related]
18. The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling. Ordóñez-Morán P, Alvarez-Díaz S, Valle N, Larriba MJ, Bonilla F, Muñoz A. J Steroid Biochem Mol Biol; 2010 Jul 01; 121(1-2):355-61. PubMed ID: 20223287 [Abstract] [Full Text] [Related]
19. Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, Holick MF. J Nutr; 2005 Oct 01; 135(10):2350-4. PubMed ID: 16177194 [Abstract] [Full Text] [Related]
20. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines. Levy Y, Knutson JC, Bishop C, Shany S. Anticancer Res; 1998 Oct 01; 18(3A):1769-75. PubMed ID: 9673403 [Abstract] [Full Text] [Related] Page: [Next] [New Search]